KBAT Group: Promising Growth, But Valuation May Be Getting Ahead Of Itself KBAT Group shows strong revenue growth and expansion potential, yet its current valuation raises concerns about sustainability. #KBATGroup #ValuationRisk
Phoenix Plus Corp. to Acquire SolarPulse Monitor Software in $960,000 Share Deal Phoenix Plus Corp. announces acquisition of SolarPulse Monitor software via $960K share transaction, expanding its tech portfolio. #PhoenixPlus #SolarPulseAcquisition
Picard Medical Pursues IPO Amid Declining Revenue and Elevated Valuation Picard Medical plans IPO despite dropping revenue and high valuation, raising questions on growth prospects. #PicardMedical #IPO
First Real Estate Investment Trust of New Jersey Elects Directors and Approves Auditor First Real Estate Investment Trust of New Jersey announces new director elections and auditor approval, reinforcing governance and financial oversight. #FirstREITNJ #CorporateGovernance
Equity Bancshares Completes $75 Million Subordinated Notes Offering Equity Bancshares successfully closes $75M subordinated notes offering to strengthen capital base and support growth. #EquityBancshares #CapitalRaise
Rafael Holdings Elects Scott Fine as Ex-Officio Director and Amends Bylaws Rafael Holdings appoints Scott Fine as ex-officio director and updates bylaws to enhance governance. #RafaelHoldings #CorporateGovernance
Republic Bancorp Reports Quarterly Results for June 2025 Republic Bancorp posts solid Q2 2025 results with revenue growth and improved net income, reflecting strong operational performance. #RepublicBancorp #Q22025Results
Stock Yards Bancorp Authorizes New Stock Repurchase Program of Up to 1 Million Shares Stock Yards Bancorp announces a new stock repurchase program authorizing up to 1 million shares, signaling confidence in long-term shareholder value. #StockYardsBancorp #StockRepurchase
Rigetti Computing Reports Achievement of Two-Qubit Gate Fidelity Milestone Rigetti Computing achieves breakthrough in two-qubit gate fidelity, advancing quantum computing capabilities. #RigettiComputing #QuantumMilestone
Sanofi Completes $9.1 Billion Acquisition of Blueprint Medicines, Nasdaq Delisting Follows Sanofi finalizes $9.1B acquisition of Blueprint Medicines, leading to Nasdaq delisting and expanded oncology portfolio. #Sanofi #BlueprintMedicines